Recruiting now
-
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Phase 2 · randomised · 120 people · 26 sites in 2 countries · Recruiting now
-
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Phase 4 · randomised · 966 people · 1 site in China · Recruiting now
-
A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
Phase 3 · randomised · 444 people · 1 site in China · Recruiting now
-
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
Phase 3 · randomised · 400 people · 1 site in Lithuania · Recruiting now
-
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
Phase 3 · randomised · 165 people · 2 sites in China · Recruiting now
-
Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial
Phase 3 · randomised · 210 people · 1 site in China · Recruiting now
-
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 3 · randomised · 308 people · 1 site in South Korea · Recruiting now
-
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Phase 3 · randomised · 156 people · 1 site in China · Recruiting now